Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
August 23, 2014Inflammatory Bowel DiseasesOpen Access

Early Infliximab Trough Levels Are Associated with Persistent Remission in Pediatric Patients with Inflammatory Bowel Disease

View Full Paper
Ask AI
Bookmark
Share

Authors

NSNamita SinghCRCasey J. RosenthalGMGil Melmed

Discussion

Loading...

Member takes

Overview

Key Points

Key points are not available for this paper at this time.

Cite This Study

Singh et al. (2014) studied this question.

synapsesocial.com/papers/6a87ef3f70098fa105bb607bhttps://doi.org/10.1097/mib.0000000000000137
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Addition of thiopurines can recapture response in patients with <scp>C</scp>rohn's disease who have lost response to anti‐tumor necrosis factor monotherapy2013 · 40 citations
  2. 2UEG Week 2013 Oral Presentations2013 · 20 citations
  3. 3Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach1988 · 23,064 citations
  4. 4Infliximab trough levels may predict sustained response to infliximab in patients with Crohn's disease2012 · 232 citations